Seattle Genetics (SGEN) Tops Q4 EPS by 2c, Beats on Revenues
Tweet
Share
E-mail
Get Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q4 EPS of ($0.41), $0.02 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $129.6 million versus the consensus estimate of $116.24 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
- Jabil (JBL) Tops Q4 EPS by 34c, Beats on Revenue; Offers FY Guidance
- Forgent Power Solutions jumps as Bernstein sees massive earnings upside
Create E-mail Alert Related Categories
Corporate News, Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
